Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
PharmaSphere: US Healthcare Policy Update – Impact Analysis of the Affordable Care Act on Stakeholders
Lipase (EC 3.1.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Post-Transplant Lymphoproliferative Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Peptide Receptor Type A or Guanylate Cyclase A or NPR1 or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players